Evidence map›Paper›PMID 27708627›Full record

ArticleFrontiers in microbiology2016

A Phenotypic and Genotypic Analysis of the Antimicrobial Potential of Cultivable

Marta Maciejewska, Delphine Adam, Loïc Martinet, Aymeric Naômé, Magdalena Całusińska, Philippe Delfosse, Monique Carnol, Hazel A Barton, Marie-Pierre Hayette, Nicolas Smargiasso and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Antifungal and other bioactive properties of the volatilome ofApplied and environmental microbiology · 2025
    Article
  6. International journal of systematic and evolutionary microbiology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Marta MaciejewskaInBioS - Centre for Protein Engineering, Institut de Chimie B6a, University of Liège Liège, Belgium.
Delphine AdamInBioS - Centre for Protein Engineering, Institut de Chimie B6a, University of Liège Liège, Belgium.
Loïc MartinetInBioS - Centre for Protein Engineering, Institut de Chimie B6a, University of Liège Liège, Belgium.
Aymeric NaôméInBioS - Centre for Protein Engineering, Institut de Chimie B6a, University of Liège Liège, Belgium.
Magdalena CałusińskaEnvironmental Research and Innovation Department, Luxembourg Institute of Science and Technology Belvaux, Luxembourg.
Philippe DelfosseEnvironmental Research and Innovation Department, Luxembourg Institute of Science and Technology Belvaux, Luxembourg.
Monique CarnolInBioS - Plant and Microbial Ecology, Botany B22, University of Liège Liège, Belgium.
Hazel A BartonDepartment of Biology, University of Akron, Akron OH, USA.
Marie-Pierre HayetteDepartment of Clinical Microbiology, University Hospital of Liège Liège, Belgium.
Nicolas SmargiassoMolSys Research Unit, Mass Spectrometry Laboratory, University of Liège Liège, Belgium.
Edwin De PauwMolSys Research Unit, Mass Spectrometry Laboratory, University of Liège Liège, Belgium.
Marc HanikenneInBioS - Functional Genomics and Plant Molecular Imaging, University of LiègeLiège, Belgium; PhytoSYSTEMS, University of LiègeLiège, Belgium.
Denis BaurainPhytoSYSTEMS, University of LiègeLiège, Belgium; InBioS - Eukaryotic Phylogenomics, University of LiègeLiège, Belgium.
Sébastien RigaliInBioS - Centre for Protein Engineering, Institut de Chimie B6a, University of Liège Liège, Belgium.
University of Liège · BELuxembourg Institute of Science and Technology · LUUniversity of Akron · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Moonmilk speleothems of limestone caves host a rich microbiome, among which Actinobacteria represent one of the most abundant phyla. Ancient medical texts reported that moonmilk had therapeutical properties, thereby suggesting that its filamentous endemic actinobacterial population might be a source of natural products useful in human treatment. In this work, a screening approach was undertaken in order to isolate cultivable Actinobacteria from moonmilk of the Grotte des Collemboles in Belgium, to evaluate their taxonomic profile, and to assess their potential in biosynthesis of antimicrobials. Phylogenetic analysis revealed that all 78 isolates were exclusively affiliated to the genus

Indexed as

cryptic antibioticsgenome mininggeomicrobiologyMLSA phylogenysecondary metabolism

Identifiers

PMID27708627
PMCPMC5030222
OpenAlexW2521241106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.